Quality Improvement Goals for Acute Kidney Injury.
Acute Kidney Injury
/ prevention & control
Community Health Services
/ standards
Congresses as Topic
Consensus
Humans
Preventive Health Services
/ standards
Primary Prevention
/ standards
Professional Role
Quality Improvement
Quality Indicators, Health Care
Renal Replacement Therapy
/ standards
Risk Assessment
/ methods
Risk Factors
Secondary Prevention
/ standards
Tertiary Prevention
/ standards
ADQI
Acute Disease
Acute Kidney Injury
Emergency Service, Hospital
Goals
Health Care Costs
Incidence
Inpatients
Management
Nurse Practitioners
Patient Discharge
Pharmacists
Prevention
Quality Improvement
Quality of Health Care
acute renal failure
hospitalization
Journal
Clinical journal of the American Society of Nephrology : CJASN
ISSN: 1555-905X
Titre abrégé: Clin J Am Soc Nephrol
Pays: United States
ID NLM: 101271570
Informations de publication
Date de publication:
07 06 2019
07 06 2019
Historique:
received:
30
01
2019
accepted:
20
03
2019
pubmed:
19
5
2019
medline:
23
9
2020
entrez:
19
5
2019
Statut:
ppublish
Résumé
AKI is a global concern with a high incidence among patients across acute care settings. AKI is associated with significant clinical consequences and increased health care costs. Preventive measures, as well as rapid identification of AKI, have been shown to improve outcomes in small studies. Providing high-quality care for patients with AKI or those at risk of AKI occurs across a continuum that starts at the community level and continues in the emergency department, hospital setting, and after discharge from inpatient care. Improving the quality of care provided to these patients, plausibly mitigating the cost of care and improving short- and long-term outcomes, are goals that have not been universally achieved. Therefore, understanding how the management of AKI may be amenable to quality improvement programs is needed. Recognizing this gap in knowledge, the 22nd Acute Disease Quality Initiative meeting was convened to discuss the evidence, provide recommendations, and highlight future directions for AKI-related quality measures and care processes. Using a modified Delphi process, an international group of experts including physicians, a nurse practitioner, and pharmacists provided a framework for current and future quality improvement projects in the area of AKI. Where possible, best practices in the prevention, identification, and care of the patient with AKI were identified and highlighted. This article provides a summary of the key messages and recommendations of the group, with an aim to equip and encourage health care providers to establish quality care delivery for patients with AKI and to measure key quality indicators.
Identifiants
pubmed: 31101671
pii: 01277230-201906000-00028
doi: 10.2215/CJN.01250119
pmc: PMC6556737
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
941-953Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK079310
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK113191
Pays : United States
Organisme : HSRD VA
ID : I01 HX001280
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM110240
Pays : United States
Informations de copyright
Copyright © 2019 by the American Society of Nephrology.
Références
Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, Edipidis K, Forni LG, Gomersall CD, Govil D, Honoré PM, Joannes-Boyau O, Joannidis M, Korhonen AM, Lavrentieva A, Mehta RL, Palevsky P, Roessler E, Ronco C, Uchino S, Vazquez JA, Vidal Andrade E, Webb S, Kellum JA: Epidemiology of acute kidney injury in critically ill patients: The multinational AKI-EPI study. Intensive Care Med 41: 1411–1423, 2015
Silver SA, Long J, Zheng Y, Chertow GM: Cost of acute kidney injury in hospitalized patients. J Hosp Med 12: 70–76, 2017
Riffaut N, Moranne O, Hertig A, Hannedouche T, Couchoud C: Outcomes of acute kidney injury depend on initial clinical features: A national French cohort study. Nephrol Dial Transplant 33: 2218–2227, 2018
Meersch M, Schmidt C, Hoffmeier A, Van Aken H, Wempe C, Gerss J, Zarbock A: Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: The PrevAKI randomized controlled trial. Intensive Care Med 43: 1551–1561, 2017
Göcze I, Jauch D, Götz M, Kennedy P, Jung B, Zeman F, Gnewuch C, Graf BM, Gnann W, Banas B, Bein T, Schlitt HJ, Bergler T: Biomarker-guided intervention to prevent acute kidney injury after major surgery: The prospective randomized BigpAK study. Ann Surg 267: 1013–1020, 2018
Selby NM, Casula A, Lamming L, Stoves J, Samarasinghe Y, Lewington AJ, Roberts R, Shah N, Johnson M, Jackson N, Jones C, Lenguerrand E, McDonach E, Fluck RJ, Mohammed MA, Caskey FJ: An organizational-level program of intervention for AKI: A pragmatic stepped wedge cluster randomized trial. J Am Soc Nephrol 30: 505–515, 2019
Stewart J, Findlay G, Smith N, Kelly K, Mason M: Acute Kidney Injury: Adding Insult To Injury, London, National Confidential Enquiry into Patient Outcome and Death, 2009. Available at: https://www.ncepod.org.uk/2009aki.html . Accessed April 9, 2019
Srisawat N, Sileanu FE, Murugan R, Bellomod R, Calzavacca P, Cartin-Ceba R, Cruz D, Finn J, Hoste EE, Kashani K, Ronco C, Webb S, Kellum JA; Acute Kidney Injury-6 Study Group: Variation in risk and mortality of acute kidney injury in critically ill patients: A multicenter study. Am J Nephrol 41: 81–88, 2015
James MT, Pannu N: Can acute kidney injury be considered a clinical quality measure. Nephron 131: 237–241, 2015
Donabedian A: Evaluating the quality of medical care. Milbank Mem Fund Q 44[Suppl]: 166–206, 1966
Rewa OG, Villeneuve PM, Lachance P, Eurich DT, Stelfox HT, Gibney RTN, Hartling L, Featherstone R, Bagshaw SM: Quality indicators of continuous renal replacement therapy (CRRT) care in critically ill patients: A systematic review. Intensive Care Med 43: 750–763, 2017
Quality Improvement Goals for Acute Kidney Injury; ADQI XXII. Acute disease quality initiative (ADQI), 2019. Available at: http://www.adqi.org/Home-Call.htm . Accessed April 9, 2019
Jha V, Parameswaran S: Community-acquired acute kidney injury in tropical countries. Nat Rev Nephrol 9: 278–290, 2013
Sawhney S, Fluck N, Fraser SD, Marks A, Prescott GJ, Roderick PJ, Black C: KDIGO-based acute kidney injury criteria operate differently in hospitals and the community-findings from a large population cohort. Nephrol Dial Transplant 31: 922–929, 2016
Kashani K, Macedo E, Burdmann EA, Hooi LS, Khullar D, Bagga A, Chakravarthi R, Mehta R: Acute kidney injury risk assessment: Differences and similarities between resource-limited and resource-rich countries. Kidney Int Rep 2: 519–529, 2017
Lapi F, Azoulay L, Yin H, Nessim SJ, Suissa S: Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: Nested case-control study. BMJ 346: e8525, 2013
Dreischulte T, Morales DR, Bell S, Guthrie B: Combined use of nonsteroidal anti-inflammatory drugs with diuretics and/or renin-angiotensin system inhibitors in the community increases the risk of acute kidney injury. Kidney Int 88: 396–403, 2015
Mitchell AM, Jones AE, Tumlin JA, Kline JA: Incidence of contrast-induced nephropathy after contrast-enhanced computed tomography in the outpatient setting. Clin J Am Soc Nephrol 5: 4–9, 2010
Emmett L, Tollitt J, McCorkindale S, Sinha S, Poulikakos D: The evidence of acute kidney injury in the community and for primary care interventions. Nephron 136: 202–210, 2017
Duceppe E, Parlow J, MacDonald P, Lyons K, McMullen M, Srinathan S, Graham M, Tandon V, Styles K, Bessissow A, Sessler DI, Bryson G, Devereaux PJ: Canadian cardiovascular society guidelines on perioperative cardiac risk assessment and management for patients who undergo noncardiac surgery. Can J Cardiol 33: 17–32, 2017
Silver SA, McQuillan R, Harel Z, Weizman AV, Thomas A, Nesrallah G, Bell CM, Chan CT, Chertow GM: How to sustain change and support continuous quality improvement. Clin J Am Soc Nephrol 11: 916–924, 2016
Mehta RL, Burdmann EA, Cerdá J, Feehally J, Finkelstein F, García-García G, Godin M, Jha V, Lameire NH, Levin NW, Lewington A, Lombardi R, Macedo E, Rocco M, Aronoff-Spencer E, Tonelli M, Zhang J, Remuzzi G: Recognition and management of acute kidney injury in the International Society of Nephrology 0by25 Global napshot: A multinational cross-sectional study. Lancet 387: 2017–2025, 2016
Hayes SL, Mann MK, Morgan FM, Kelly MJ, Weightman AL: Collaboration between local health and local government agencies for health improvement. Cochrane Database Syst Rev 10: CD007825, 2012
Malhotra R, Kashani KB, Macedo E, Kim J, Bouchard J, Wynn S, Li G, Ohno-Machado L, Mehta R: A risk prediction score for acute kidney injury in the intensive care unit. Nephrol Dial Transplant 32: 814–822, 2017
Koyner JL, Carey KA, Edelson DP, Churpek MM: The development of a machine learning inpatient acute kidney injury prediction model. Crit Care Med 46: 1070–1077, 2018
KDIGO: Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guideline for acute kidney injury. Kidney Int Suppl 2: 1–138, 2012
National Clinical Guideline Centre: Acute Kidney Injury: Prevention, Detection and Management Up to the Point of Renal Replacement Therapy, National Institute for Health and Clinical Excellence: Guidance, London, Royal College of Physicians, 2013
Joannidis M, Druml W, Forni LG, Groeneveld ABJ, Honore PM, Hoste E, Ostermann M, Oudemans-van Straaten HM, Schetz M: Prevention of acute kidney injury and protection of renal function in the intensive care unit: Update 2017: Expert opinion of the Working Group on Prevention, AKI section, European Society of Intensive Care Medicine. Intensive Care Med 43: 730–749, 2017
Moore PK, Hsu RK, Liu KD: Management of acute kidney injury: Core curriculum 2018. Am J Kidney Dis 72: 136–148, 2018
Kanagasundaram S: The NICE acute kidney injury guideline: Questions still unanswered. Br J Hosp Med (Lond) 74: 664–665, 2013
Hobson C, Ruchi R, Bihorac A: Perioperative acute kidney injury: Risk factors and predictive strategies. Crit Care Clin 33: 379–396, 2017
Ftouh S, Lewington A; Acute Kidney Injury Guideline Development Group convened by the National Clinical Guidelines Centre and commissioned by the National Institute for Health and Care Excellence, in association with The Royal College of Physicians’ Clini: Prevention, detection and management of acute kidney injury: Concise guideline. Clin Med (Lond) 14: 61–65, 2014
Hobson C, Lysak N, Huber M, Scali S, Bihorac A: Epidemiology, outcomes, and management of acute kidney injury in the vascular surgery patient. J Vasc Surg 68: 916–928, 2018
Ostermann M, Joannidis M: Acute kidney injury 2016: Diagnosis and diagnostic workup. Crit Care 20: 299, 2016
Selby NM, Casula A, Lamming L, Mohammed M, Caskey F; Tackling AKI Investigators: Design and rationale of ‘tackling acute kidney injury’, a multicentre quality improvement study. Nephron 134: 200–204, 2016
Kolhe NV, Reilly T, Leung J, Fluck RJ, Swinscoe KE, Selby NM, Taal MW: A simple care bundle for use in acute kidney injury: A propensity score-matched cohort study. Nephrol Dial Transplant 31: 1846–1854, 2016
Ebah L, Hanumapura P, Waring D, Challiner R, Hayden K, Alexander J, Henney R, Royston R, Butterworth C, Vincent M, Heatley S, Terriere G, Pearson R, Hutchison A: A multifaceted quality improvement programme to improve acute kidney injury care and outcomes in a large teaching hospital. BMJ Qual Improv Rep 6: u219176.w7476, 2017
Cox ZL, McCoy AB, Matheny ME, Bhave G, Peterson NB, Siew ED, Lewis J, Danciu I, Bian A, Shintani A, Ikizler TA, Neal EB, Peterson JF: Adverse drug events during AKI and its recovery. Clin J Am Soc Nephrol 8: 1070–1078, 2013
Barreto EF, Mueller BA, Kane-Gill SL, Rule AD, Steckelberg JM: β-Lactams: The competing priorities of nephrotoxicity, neurotoxicity, and stewardship. Ann Pharmacother 52: 1167–1168, 2018
Ostermann M, Chawla LS, Forni LG, Kane-Gill SL, Kellum JA, Koyner J, Murray PT, Ronco C, Goldstein SL; ADQI 16 workgroup: Drug management in acute kidney disease - Report of the Acute Disease Quality Initiative XVI meeting. Br J Clin Pharmacol 84: 396–403, 2018
Goldstein SL, Mottes T, Simpson K, Barclay C, Muething S, Haslam DB, Kirkendall ES: A sustained quality improvement program reduces nephrotoxic medication-associated acute kidney injury. Kidney Int 90: 212–221, 2016
Schanz M, Wasser C, Allgaeuer S, Schricker S, Dippon J, Alscher MD, Kimmel M: Urinary [TIMP-2]·[IGFBP7]-guided randomized controlled intervention trial to prevent acute kidney injury in the emergency department [published online ahead of print June 28, 2018]. Nephrol Dial Transplant 10.1093/ndt/gfy186
doi: 10.1093/ndt/gfy186
Barreto EF, Rule AD, Voils SA, Kane-Gill SL: Innovative use of novel biomarkers to improve the safety of renally eliminated and nephrotoxic medications. Pharmacotherapy 38: 794–803, 2018
Rewa O, Mottes T, Bagshaw SM: Quality measures for acute kidney injury and continuous renal replacement therapy. Curr Opin Crit Care 21: 490–499, 2015
Rewa OG, Eurich DT, Noel Gibney RT, Bagshaw SM: A modified Delphi process to identify, rank and prioritize quality indicators for continuous renal replacement therapy (CRRT) care in critically ill patients. J Crit Care 47: 145–152, 2018
United States Renal Data System: USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2018, Available at: https://www.usrds.org/2018/view/v1_05.aspx . Accessed April 9, 2019
Karsanji DJ, Pannu N, Manns BJ, Hemmelgarn BR, Tan Z, Jindal K, Scott-Douglas N, James MT: Disparity between nephrologists’ opinions and contemporary practices for community follow-up after AKI hospitalization. Clin J Am Soc Nephrol 12: 1753–1761, 2017